Strep throat, also known as Group A streptococcal pharyngitis, is a common bacterial infection of the throat and tonsils caused by streptococcal bacteria. Strep throat causes pain and difficulty swallowing.
If left untreated, the infection can spread to other parts of the body. The increasing cases of Strep Throat Treatment Market Size And Trends across the world are expected to drive the growth of the global strep throat treatment market during the forecast period.
The global strep throat treatment market is estimated to be valued at US$ 2.08 Bn in 2024 and is expected to exhibit a CAGR of 4.4% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global strep throat treatment market are Pfizer Inc., Sanofi, Astrazeneca, Novartis AG, Bayer AG, GSK plc, Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Merck co, Inc., Johnson Johnson Service, Inc., Accord Healthcare, Amneal Pharmaceuticals LLC., MiddleBrook Pharmaceuticals, Inc., Taiho Pharmaceutical Co., Ltd.
The increasing awareness regarding Strep Throat Treatment Market Demand options and the availability of generic drugs provides key opportunities for players in the market. Further, improving access to healthcare in developing countries will drive the global expansion of the strep throat treatment market.
The rising prevalence of strep throat infections, increasing research funding for development of novel drugs, and growing demand for over-the-counter drugs are expected to drive the growth of the global strep throat treatment market during the forecast period.
Get More Insights On, Global Strep Throat Treatment Market
For More Insights Discover the Report In language that Resonates with you
